A detailed history of Ing Groep Nv transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Ing Groep Nv holds 286,500 shares of TXG stock, worth $3.55 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
286,500
Previous 191,800 49.37%
Holding current value
$3.55 Million
Previous $1.67 Million 98.15%
% of portfolio
0.02%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 06, 2025

BUY
$7.14 - $11.73 $676,158 - $1.11 Million
94,700 Added 49.37%
286,500 $3.32 Million
Q1 2025

May 09, 2025

BUY
$8.73 - $16.31 $1.02 Million - $1.9 Million
116,400 Added 154.38%
191,800 $1.67 Million
Q4 2024

Feb 03, 2025

BUY
$13.18 - $21.31 $993,772 - $1.61 Million
75,400 New
75,400 $1.08 Million
Q1 2024

May 10, 2024

BUY
$36.08 - $54.3 $1.67 Million - $2.52 Million
46,400 New
46,400 $1.74 Million

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.18B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Ing Groep Nv Portfolio

Follow Ing Groep Nv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ing Groep Nv, based on Form 13F filings with the SEC.

News

Stay updated on Ing Groep Nv with notifications on news.